Results 11 to 20 of about 2,263 (160)
Safety and Efficacy of a 24-Cycle Administration of a Drospirenone-Only Pill in Japanese Women. [PDF]
J Obstet Gynaecol ResABSTRACT Aim We conducted a 24‐cycle study to evaluate long‐term safety of 4 mg of drospirenone (DRSP), a progestin‐only pill (POP), for contraception in Japanese women. Methods A multicenter, single‐arm 24‐cycle study was conducted in women who participated in the 13 cycle study of DRSP.
Kitamura K +5 more
europepmc +2 more sources
Synthetic estrogen and progestin effects on the myogenic program following damage in C2C12 murine myoblasts. [PDF]
Physiol RepThe effect of oral contraceptives (OCs) on muscle repair is unknown. Using electrical pulse stimulation to simulate damage in C2C12 myoblasts treated with four OC generations (MPA, LNG, DSG, DRP combined with ethinyl estradiol), we assessed proliferation, differentiation, migration, creatine kinase, myogenic proteins, and hormone receptor protein ...
Wageh M, Kamal M, Parise G.
europepmc +2 more sources
Frontiers in Medicine, 2022 AimThis systematic review aimed to assess the efficacy and safety of Drospirenone and Ethinylestradiol Tablets (II) in the treatment of dysmenorrhea.MethodsElectronic databases, namely PubMed, Embase, Cochrane Controlled Register of Trials (CENTRAL ...
Jinghua Shi +3 more
doaj +1 more source
Personalized approach of a hormonal contraceptive for patients requiring control of body weight (review) [PDF]
Гинекология, 2018 Hormonal contraceptives are protected from undesirable pregnancy, but also have a row of other useful, uncontraceptive effects, both in regard to the reproductive system and all organism on the whole.
T Yu Pestrikova, E A Yurasova
doaj +1 more source
Türk Kardiyoloji Derneği Arşivi, 2018 Although the use of oral contraceptives is associated with an increased risk of venous thromboembolic disease, the risk of myocardial infarction (MI) is unclear.
Hüsnü Atmaca +4 more
doaj +1 more source
Considerations for Menstrual Suppression in Patients With Hematologic Malignancies. [PDF]
PharmacotherapyABSTRACT Patients who menstruate during treatment for hematologic malignancies have a higher risk of heavy vaginal bleeding due to thrombocytopenia caused by malignancy and myelosuppressive chemotherapy. Heavy menstrual bleeding is associated with significant morbidity in this patient population, and menstrual suppression is a standard of supportive ...
Veeravalli S +3 more
europepmc +2 more sources
Anti-Neuroinflammatory Potential of Drospirenone in A TLR4-Driven In Vitro Model of Neuropathic Pain [PDF]
Cell JournalObjective: Neuroinflammation plays a crucial role in neuropathic pain, of which toll-like receptor 4 (TLR4) is a key mediator. Virtual screening identified Drospirenone as a potential TLR4 inhibitor.
Leila Taheran +6 more
doaj +1 more source
Brazilian Journal of Pharmaceutical Sciences, 2013 A simple, rapid, economical and reliable high performance liquid chromatographic method has been developed and successfully applied in simultaneous determination of ethinyl estradiol and drospirenone in coated tablets.
Viviane Benevenuti Silva +7 more
doaj +1 more source
Reviews in Analytical Chemistry, 2012 This paper describes a new, simple, precise, and accurate HPTLC method for simultaneous estimation of ethinyl estradiol and drospirenone as bulk drug and in tablet dosage forms.
Bhusari Vidhya K., Dhaneshwar Sunil R.
doaj +1 more source